X
20
Aurobindo Pharma Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is CARISOPRODOL USP, with a corresponding US DMF Number 19388.
Remarkably, this DMF maintains an Active status since its submission on April 18, 2006, highlighting commitment to regulatory compliance.